Keyphrases
Cerebral Blood Flow
100%
Oxygen Metabolism
100%
Alzheimer's Disease
100%
Regional Variability
100%
Blood Oxygenation
100%
Inter-individual Variability
100%
Glucose Transporter 1 (GLUT1)
85%
Blood-brain Barrier
71%
GLP-1 Analogue
57%
Tmax
42%
Blood-brain
28%
Liraglutide
28%
Glucose Transport
28%
Brain Glucose
28%
Synaptic Dysfunction
28%
Therapeutic Target
28%
Glucagon-like peptide-1 (GLP-1)
28%
Cerebral Glucose Metabolism
14%
Capillary Endothelium
14%
Transport Capacity
14%
Cognitive Function
14%
18F-fluorodeoxyglucose (18F-FDG)
14%
Alzheimer's Disease Pathology
14%
Placebo
14%
Brain Tissue
14%
Brain Capillaries
14%
Disease Evolution
14%
Endothelium
14%
Cognitive Impairment
14%
Placebo Treatment
14%
Incretin Hormones
14%
Cerebral Cortex
14%
Facilitated Diffusion
14%
Neuroscience
Alzheimer's Disease
100%
Metabolic Pathway
100%
Glucose Transporter 1
75%
Glucagon-Like Peptide-1
75%
Blood Brain Barrier
62%
Glucose Transport
37%
Placebo
25%
Liraglutide
25%
Incretin
12%
Cognitive Function
12%
Cognitive Disorder
12%
Cerebral Cortex
12%
Blood Plasma
12%
Fluorine-18
12%
Immunology and Microbiology
Brain Blood Flow
100%
Glucose Transporter
100%
Blood Brain Barrier
83%
Glucose Transport
50%
Glucose Brain Level
33%
Incretin
16%
Metabolic Rate
16%
Brain Capillary Endothelium
16%
Diffusion
16%
Cognition
16%
Blood Plasma
16%
Brain Tissue
16%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Glucose Transporter 1
75%
Glucagon-Like Peptide-1
75%
Blood-Brain Barrier
62%
Liraglutide
25%
Placebo
25%
Disease Course
12%
Incretin
12%
Fluorodeoxyglucose F 18
12%
Cognitive Defect
12%